Research & Development

Focus on the unmet needs of patient, follow the science

We create innovative medicines and prioritize our work based on unmet medical need and strong scientific understanding of drug development –patient needs and the size of the potential commercial market.

Avanti researchers are working to develop novel approaches to develop and improve existing drug molecules to commercialize that are patient and regulatory agency friendly- better quality and efficacy attributes. Utilizing the Aayush- an innovative product development platform, Avanti researchers are developing product pipelines with wide range of domain independent life science products.

To translate scientific discoveries from the lab bench to the clinic, Avanti uses proof-of-concept clinical trials (small scale studies used to get an early read on a drug’s safety and effectiveness) to help find and advance the most promising drug and diagnostic candidates. These proof-of-concept studies often focus on the products with significant positive impact on patients as well as corporate growth.

“We build foundations for sustainable product pipelines across different life science domains where there is significant unmet need and where the science is strongest.”

Arkesh Mehta, Ph.D., Chairman and member of the Executive Committee of Avanti Therapeutics.

 By focusing on the patient and utilizing its innovative product development platform, Avanti Therapeutics is validating number of proof of concept studies for disorders ranging from cancer to degenerative disease

Thanks to this approach, Avanti Therapeutics has one of the strongest and most productive pipelines in the start-up company landscape, with sustainable product development platforms for

Oncology

Cardiovascular diseases

CNS

Vaccines

Regenerative Medicine

Molecular Diagnostics

Life Science Tool Kit.